{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:50:53Z","timestamp":1791409853477,"version":"4.3.3"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100031918","name":"State Key Laboratory of Natural and Biomimetic Drugs","doi-asserted-by":"publisher","award":["KF2025003"],"award-info":[{"award-number":["KF2025003"]}],"id":[{"id":"10.13039\/100031918","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015285","name":"Hebei Province Medical Science Research Key Project","doi-asserted-by":"publisher","award":["20220200"],"award-info":[{"award-number":["20220200"]}],"id":[{"id":"10.13039\/501100015285","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015285","name":"Hebei Province Medical Science Research Key Project","doi-asserted-by":"publisher","award":["20240241"],"award-info":[{"award-number":["20240241"]}],"id":[{"id":"10.13039\/501100015285","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003787","name":"Natural Science Foundation of Hebei Province","doi-asserted-by":"publisher","award":["H2024206375"],"award-info":[{"award-number":["H2024206375"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012505","name":"Hebei Medical University","doi-asserted-by":"publisher","award":["CYQD2023012"],"award-info":[{"award-number":["CYQD2023012"]}],"id":[{"id":"10.13039\/501100012505","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012505","name":"Hebei Medical University","doi-asserted-by":"publisher","award":["CYCZ2023011"],"award-info":[{"award-number":["CYCZ2023011"]}],"id":[{"id":"10.13039\/501100012505","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012505","name":"Hebei Medical University","doi-asserted-by":"publisher","award":["CYCZ2023010"],"award-info":[{"award-number":["CYCZ2023010"]}],"id":[{"id":"10.13039\/501100012505","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bioorg.2026.110427","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T14:42:29Z","timestamp":1787409749000},"page":"110427","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design, synthesis, and biological evaluation of selective HDAC6 inhibitors featuring an N-benzyl-2-(aryl\/heteroaryl)acetamide cap"],"prefix":"10.1016","volume":"181","author":[{"given":"Tingting","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingfang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenying","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusha","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiteng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaobo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingfan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingzhong","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuedong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.110427_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115752","article-title":"Design, synthesis, and biological evaluation of novel HDAC\/CD13 dual inhibitors for the treatment of cancer","volume":"260","author":"Jia","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110427_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103184","article-title":"Small molecule HDAC inhibitors: promising agents for breast cancer treatment","volume":"91","author":"Huang","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110427_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115673","article-title":"A review of progress in o-aminobenzamide-based HDAC inhibitors with dual targeting capabilities for cancer therapy","volume":"259","author":"Zhang","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110427_bb0020","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ccell.2019.09.005","article-title":"Re-programing chromatin with a bifunctional LSD1\/HDAC inhibitor induces therapeutic differentiation in DIPG","volume":"36","author":"Anastas","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bioorg.2026.110427_bb0025","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1021\/acs.jmedchem.2c01191","article-title":"BET-HDAC dual inhibitors for combinational treatment of breast cancer and concurrent candidiasis","volume":"66","author":"Huang","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110427_bb0030","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.semcancer.2020.11.005","article-title":"Anticancer properties of chimeric HDAC and kinase inhibitors","volume":"83","author":"Biersack","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bioorg.2026.110427_bb0035","doi-asserted-by":"crossref","first-page":"4950","DOI":"10.1021\/acs.jmedchem.4c00090","article-title":"Design, synthesis, and structure-activity relationship of novel Pyridazinone-based PARP7\/HDACs dual inhibitors for elucidating the relationship between antitumor immunity and HDACs inhibition","volume":"67","author":"Duan","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110427_bb0040","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1158\/1078-0432.CCR-15-1435","article-title":"Romidepsin and azacitidine synergize in their epigenetic modulatory effects to induce apoptosis in CTCL","volume":"22","author":"Rozati","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bioorg.2026.110427_bb0045","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13045-024-01551-8","article-title":"Advances in targeting histone deacetylase for treatment of solid tumors","volume":"17","author":"Shi","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bioorg.2026.110427_bb0050","doi-asserted-by":"crossref","first-page":"14171","DOI":"10.1021\/acs.jmedchem.5c01677","article-title":"Advancements in hydrazide-based HDAC inhibitors: a review of recent developments and therapeutic potential","volume":"68","author":"Raucci","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110427_bb0055","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.semcancer.2025.05.008","article-title":"HDAC inhibitors: cardiotoxicity and paradoxical cardioprotective effect in ischemia-reperfusion myocardiocyte injury","volume":"113","author":"K.K.W. To","year":"2025","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bioorg.2026.110427_bb0060","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41419-023-06303-z","article-title":"Novel dual inhibitors of PARP and HDAC induce intratumoral STING-mediated antitumor immunity in triple-negative breast cancer","volume":"15","author":"Zhu","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bioorg.2026.110427_bb0065","doi-asserted-by":"crossref","first-page":"12460","DOI":"10.1021\/acs.jmedchem.0c00830","article-title":"Thirty years of HDAC inhibitors: 2020 insight and hindsight","volume":"63","author":"Ho","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110427_bb0070","doi-asserted-by":"crossref","first-page":"6147","DOI":"10.1021\/acs.jcim.4c01052","article-title":"Discovery of potent selective HDAC6 inhibitors with 5-phenyl-1H-indole fragment: virtual screening, rational design, and biological evaluation","volume":"64","author":"Li","year":"2024","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2026.110427_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105278","article-title":"Development of selective HDAC6 inhibitors with in vitro and in vivo anti-multiple myeloma activity","volume":"116","author":"Li","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110427_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105274","article-title":"HDAC6 as privileged target in drug discovery: a perspective","volume":"163","author":"Pulya","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bioorg.2026.110427_bb0085","doi-asserted-by":"crossref","first-page":"13459","DOI":"10.1073\/pnas.1718823114","article-title":"Unusual zinc-binding mode of HDAC6-selective hydroxamate inhibitors","volume":"114","author":"Porter","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bioorg.2026.110427_bb0090","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202304545","article-title":"Structure-based discovery of a small molecule inhibitor of histone deacetylase 6 (HDAC6) that significantly reduces Alzheimer's disease neuropathology","volume":"11","author":"Mondal","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bioorg.2026.110427_bb0095","doi-asserted-by":"crossref","first-page":"9279","DOI":"10.1021\/acs.jmedchem.4c02883","article-title":"Development of hydrazide-based HDAC6 selective inhibitors for treating NLRP3 inflammasome-related diseases","volume":"68","author":"Yue","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110427_bb0100","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1038\/s43018-024-00816-y","article-title":"Phase separation of phospho-HDAC6 drives aberrant chromatin architecture in triple-negative breast cancer","volume":"5","author":"Lu","year":"2024","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.bioorg.2026.110427_bb0105","doi-asserted-by":"crossref","first-page":"15738","DOI":"10.1021\/acs.jmedchem.5c00717","article-title":"Structure-based discovery of Hsp90\/HDAC6 dual inhibitors targeting aggressive prostate cancer","volume":"68","author":"Citarella","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110427_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116884","article-title":"Brindisi, tackling triple negative breast cancer with HDAC inhibitors: 6 is the isoform!","volume":"279","author":"Guadagni","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110427_bb0115","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007588","article-title":"Dual molecule targeting HDAC6 leads to intratumoral CD4+ cytotoxic lymphocytes recruitment through MHC-II upregulation on lung cancer cells","volume":"12","author":"Ducellier","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bioorg.2026.110427_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2025.101338","article-title":"Discovery of selective HDAC6 inhibitors driven by artificial intelligence and molecular dynamics simulation approaches","volume":"15","author":"Liu","year":"2025","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.bioorg.2026.110427_bb0125","article-title":"HDAC6 and USP9X control glutamine metabolism by stabilizing GS to promote glioblastoma tumorigenesis","volume":"12","author":"Kim","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bioorg.2026.110427_bb0130","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41388-020-01550-2","article-title":"HDAC6 promotes growth, migration\/invasion, and self-renewal of rhabdomyosarcoma","volume":"40","author":"Pham","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.bioorg.2026.110427_bb0135","doi-asserted-by":"crossref","first-page":"eadp3687","DOI":"10.1126\/sciadv.adp3687","article-title":"The HDAC6 inhibitor AVS100 (SS208) induces a pro-inflammatory tumor microenvironment and potentiates immunotherapy","volume":"10","author":"Kovalovsky","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bioorg.2026.110427_bb0140","article-title":"Overcome the tumor immunotherapy resistance by combination of the HDAC6 inhibitors with antitumor immunomodulatory agents","volume":"109","author":"Yussuf","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110427_bb0145","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jare.2022.06.009","article-title":"Rational design of synthetically tractable HDAC6\/HSP90 dual inhibitors to destroy immune-suppressive tumor microenvironment","volume":"46","author":"Wu","year":"2023","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.bioorg.2026.110427_bb0150","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40425-019-0517-0","article-title":"HDAC6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristics","volume":"7","author":"Laino","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bioorg.2026.110427_bb0155","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s10495-017-1364-4","article-title":"Ricolinostat, a selective HDAC6 inhibitor, shows anti-lymphoma cell activity alone and in combination with bendamustine","volume":"22","author":"Cosenza","year":"2017","journal-title":"Apoptosis"},{"key":"10.1016\/j.bioorg.2026.110427_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116571","article-title":"Advances in dual-targeting inhibitors of HDAC6 for cancer treatment","volume":"275","author":"Gu","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110427_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106622","article-title":"Recent development of selective inhibitors targeting the HDAC6 as anti-cancer drugs: structure, function and design","volume":"138","author":"Peng","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110427_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112998","article-title":"Novel quinolone-based potent and selective HDAC6 inhibitors: synthesis, molecular modeling studies and biological investigation","volume":"212","author":"Relitti","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110427_bb0175","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1021\/acs.jmedchem.1c01585","article-title":"Discovery of HDAC6-selective inhibitor NN-390 with in vitro efficacy in group 3 medulloblastoma","volume":"65","author":"Nawar","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110427_bb0180","doi-asserted-by":"crossref","first-page":"18216","DOI":"10.1021\/acs.jmedchem.5c00479","article-title":"Improved pharmacokinetic profiles of HDAC6 inhibitors via cap group modifications","volume":"68","author":"Olaoye","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110427_bb0185","doi-asserted-by":"crossref","first-page":"14333","DOI":"10.1021\/acs.jmedchem.5c00278","article-title":"Discovery of TNI-97 as a highly selective, orally bioavailable HDAC6 inhibitor for the treatment of triple-negative breast cancer","volume":"68","author":"Wang","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110427_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113526","article-title":"Design, synthesis and biological evaluation of 3, 4-disubstituted-imidazolidine-2, 5-dione derivatives as HDAC6 selective inhibitors","volume":"221","author":"Liang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110427_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114228","article-title":"Novel biphenyl-based scaffold as potent and selective histone deacetylase 6 (HDAC6) inhibitors: identification, development and pharmacological evaluation","volume":"233","author":"Xu","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110427_bb0200","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1021\/acs.jmedchem.1c01863","article-title":"Discovery of novel histone deacetylase 6 (HDAC6) inhibitors with enhanced antitumor immunity of anti-PD-L1 immunotherapy in melanoma","volume":"65","author":"Peng","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110427_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105874","article-title":"Design, synthesis, and biological evaluation of HDAC6 inhibitors based on cap modification strategy","volume":"125","author":"Li","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110427_bb0210","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.1021\/jm7009217","article-title":"Design, synthesis, structure--selectivity relationship, and effect on human cancer cells of a novel series of histone deacetylase 6-selective inhibitors","volume":"50","author":"Itoh","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110427_bb0215","doi-asserted-by":"crossref","first-page":"4809","DOI":"10.1021\/jm060554y","article-title":"Highly potent and selective histone deacetylase 6 inhibitors designed based on a small-molecular substrate","volume":"49","author":"Suzuki","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110427_bb0220","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1021\/acsmedchemlett.5c00024","article-title":"Potential of histone deacetylase 6 inhibitors as a treatment of neurodegenerative diseases","volume":"16","author":"Abdel-Magid","year":"2025","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110427_bb0225","doi-asserted-by":"crossref","first-page":"10842","DOI":"10.1021\/ja102758v","article-title":"Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin a","volume":"132","author":"Butler","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2026.110427_bb0230","doi-asserted-by":"crossref","first-page":"9891","DOI":"10.1021\/jm301098e","article-title":"Selective histone deacetylase 6 inhibitors bearing substituted urea linkers inhibit melanoma cell growth","volume":"55","author":"Bergman","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110427_bb0235","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1021\/acs.jmedchem.8b01590","article-title":"Quinazolin-2,4-dione-based hydroxamic acids as selective histone deacetylase-6 inhibitors for treatment of non-small cell lung cancer","volume":"62","author":"Yu","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110427_bb0240","doi-asserted-by":"crossref","first-page":"21223","DOI":"10.1021\/acs.jmedchem.4c02024","article-title":"Deciphering the therapeutic potential of novel pentyloxyamide-based class I, IIb HDAC inhibitors against therapy-resistant leukemia","volume":"67","author":"Fischer","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110427_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118184","article-title":"Design, synthesis, and biological evaluation of quinazolin-4-one-based selective HDAC6 inhibitors targeting serine 531, histidine 614 residues, and the L1 and L2 loop","volume":"300","author":"Gupta","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110427_bb0250","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12967-015-0753-0","article-title":"Both HDAC5 and HDAC6 are required for the proliferation and metastasis of melanoma cells","volume":"14","author":"Liu","year":"2016","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bioorg.2026.110427_bb0255","doi-asserted-by":"crossref","first-page":"20003","DOI":"10.1073\/pnas.1013754107","article-title":"Selective inhibition of histone deacetylase 6 (HDAC6) induces DNA damage and sensitizes transformed cells to anticancer agents","volume":"107","author":"Namdar","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bioorg.2026.110427_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108454","article-title":"Unlocking the potential of novel tetrahydro-\u03b2-carboline-based HDAC6 inhibitors for colorectal cancer therapy: design, synthesis and biological evaluation","volume":"160","author":"Hemida","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110427_bb0265","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1021\/acs.jcim.3c00168","article-title":"Diphenyl diselenide and SARS-CoV-2: in silico exploration of the mechanisms of inhibition of Main protease (Mpro) and papain-like protease (PLpro)","volume":"63","author":"Omage","year":"2023","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2026.110427_bb0270","doi-asserted-by":"crossref","first-page":"6378","DOI":"10.1021\/jp810292n","article-title":"Universal solvation model based on solute electron density and on a continuum model of the solvent defined by the bulk dielectric constant and atomic surface tensions","volume":"113","author":"Marenich","year":"2009","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.bioorg.2026.110427_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153310","article-title":"Caffeic acid derivatives (CAFDs) as inhibitors of SARS-CoV-2: CAFDs-based functional foods as a potential alternative approach to combat COVID-19","volume":"85","author":"Adem","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bioorg.2026.110427_bb0280","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jconrel.2024.12.021","article-title":"A preclinical design approach for translation of biohybrid photosensitive nanoplatform for photodynamic therapy of breast cancer","volume":"378","author":"Imanparast","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioorg.2026.110427_bb0285","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmaco-kinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.110427_bb0290","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: predicting small-molecule pharmaco-kinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110427_bb0295","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110427_bb0300","series-title":"Schr\u00f6dinger Release 2026-2: Maestro","year":"2025"},{"key":"10.1016\/j.bioorg.2026.110427_bb0305","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jhazmat.2018.08.029","article-title":"Effects of oxygen functional complexes on arsenic adsorption over carbonaceous surface","volume":"360","author":"Gao","year":"2018","journal-title":"J. Hazard. Mater."},{"key":"10.1016\/j.bioorg.2026.110427_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112888","article-title":"1-BENZYLSPIRO[PIPERIDINE-4,1'-PYRIDO[3,4-b]indole] \u2018co-potentiators\u2019 for minimal function CFTR mutants","volume":"209","author":"Son","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110427_bb0315","doi-asserted-by":"crossref","first-page":"13015","DOI":"10.1039\/D0SC04566G","article-title":"Flat corannulene: when a transition state becomes a stable molecule","volume":"11","author":"Solel","year":"2020","journal-title":"Chem. Sci."},{"key":"10.1016\/j.bioorg.2026.110427_bb0320","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.1021\/acs.jcim.9b00739","article-title":"VMD store-a VMD plugin to browse, discover, and install VMD extensions","volume":"59","author":"Fernandes","year":"2019","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2026.110427_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108953","article-title":"Green approach to the synthesis of 3,4-dihydropyrimidinone with zirconyl oxychloride as catalyst: in vitro antidiabetic evaluation, molecular dynamic simulation, density functional theory and toxicity assessment","volume":"165","author":"Monisha","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110427_bb0330","doi-asserted-by":"crossref","first-page":"6183","DOI":"10.1021\/acs.jcim.3c01153","article-title":"AmberTools","volume":"63","author":"Case","year":"2023","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2026.110427_bb0335","doi-asserted-by":"crossref","first-page":"7835","DOI":"10.1021\/acs.jcim.5c01063","article-title":"Recent developments in Amber biomolecular simulations","volume":"65","author":"Case","year":"2025","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2026.110427_bb0340","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1021\/acs.jcim.1c01109","article-title":"Multiscale workflow for modeling ligand complexes of zinc metalloproteins","volume":"61","author":"Yang","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2026.110427_bb0345","doi-asserted-by":"crossref","first-page":"5301","DOI":"10.1021\/acs.chemrev.5b00584","article-title":"Semiempirical quantum mechanical methods for noncovalent interactions for chemical and biochemical applications","volume":"116","author":"Christensen","year":"2016","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2026.110427_bb0350","doi-asserted-by":"crossref","first-page":"5337","DOI":"10.1021\/acs.jctc.4c00439","article-title":"CHARMM-GUI QM\/MM interfacer for a quantum mechanical and molecular mechanical (QM\/MM) simulation setup: 1. Semiempirical methods","volume":"20","author":"Suh","year":"2024","journal-title":"J. Chem. Theory Comput."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826009636?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826009636?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:05:05Z","timestamp":1791407105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826009636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":70,"alternative-id":["S0045206826009636"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110427","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and biological evaluation of selective HDAC6 inhibitors featuring an N-benzyl-2-(aryl\/heteroaryl)acetamide cap","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110427","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110427"}}